Schonfeld Strategic Advisors LLC Catalyst Biosciences, Inc. Transaction History

Schonfeld Strategic Advisors LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$0.91 - $4.16 $81,354 - $371,904	-89,400 Closed	0 $0
Q3 2021 Nov 16, 2021	SELL	$3.78 - $5.18 $20,412 - $27,972	-5,400 Reduced 5.7%	89,400 $367,000
Q2 2021 Aug 16, 2021	BUY	$4.1 - $5.33 $38,540 - $50,102	9,400 Added 11.01%	94,800 $411,000
Q1 2021 May 17, 2021	BUY	$4.93 - $7.15 $421,022 - $610,610	85,400 New	85,400 $431,000
Q4 2020 Feb 16, 2021	SELL	$4.55 - $7.29 $61,425 - $98,415	-13,500 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$4.22 - $6.04 $310,773 - $444,803	-73,643 Reduced 84.51%	13,500 $0
Q2 2020 Aug 14, 2020	BUY	$3.76 - $8.01 $327,657 - $698,015	87,143 New	87,143 $511,000
Q3 2018 Nov 14, 2018	SELL	$9.35 - $12.44 $472,175 - $628,220	-50,500 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$9.11 - $28.88 $215,260 - $682,405	23,629 Added 87.93%	50,500 $589,000
Q1 2018 May 15, 2018	BUY	$14.18 - $35.6 $381,030 - $956,607	26,871 New	26,871 $693,000

215

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.